Clinically tested medical device for vaginal dryness, altered pH, and intimate discomfort Vaginal dryness and altered vaginal pH are common issues affecting women of all ages, particularly during menopause, postpartum, or periods of physical and emotional stress. Typical symptoms include burning, itching, pain during intercourse, irritation, abnormal discharge, and emotional or sexual distress that can…
Treatment of reflux in infants: clinical results with Reflucalm Gastroesophageal reflux in infants is a common condition characterized by frequent regurgitation, inconsolable crying, sleep disturbances, and feeding difficulties. When persistent, these symptoms can cause significant stress for parents and impact the infant’s overall well-being. Reflucalm is a medical device specifically designed for the treatment of…
Lattawin Ovules: the effective medical device against irritation and intimate burning Dryness, burning, itching, irritation, and discomfort during intercourse are common but often overlooked symptoms that affect many women at all stages of life. Whether due to hormonal changes, menopause, stress, antibiotic use, or imbalances in the vaginal microbiota, these disturbances can compromise quality of…
MDR Transition Extended Beyond 2024: Ongoing Market Access for Our Nasal Kits The MDR (Medical Device Regulation), in force since May 2017 and fully applicable from May 2021, governs medical devices across Europe. Thanks to the extended transition timelines, devices compliant with the MDD Directive can remain on the market until December 31, 2027, for…
Ensured Continuity: Our Osteoarticular Line Is Ready for the MDR Future The Medical Device Regulation (MDR), in force since May 2017 and fully applicable as of May 2021, governs medical devices in Europe. Thanks to deadline extensions, devices compliant with the previous MDD Directive may continue to be marketed until December 31, 2027 for Class…
Fertility support with a biocompatible and clinically tested formulation From 2022, our vaginal gel is officially registered in cambodia. This important recognition confirms the safety and effectiveness of a formulation designed to support natural conception in a simple, targeted, and physiologically respectful way. This medical device was developed to create an optimal vaginal environment for…
Topical gel and anal solution for the treatment of anorectal disorders The MDR (Medical Device Regulation), in force since May 2017 and fully applicable from May 2021, governs medical devices in Europe. Thanks to deadline extensions, devices compliant with the MDD Directive can continue to be marketed until December 31, 2027, for Class III and…
MDD Certification for Our Vaginal Ovules: A New Milestone for Intimate Health The MDR Regulation, in force since May 2017 and applicable from May 2021, governs European medical devices. Deadline extensions allow medical devices compliant with the Medical Device Directive (MDD) to be marketed until December 31, 2027, for Class III and implantable Class IIb…
From a scientific perspective, Clinical Trials refer to the systematic study method conducted on humans (patients or healthy volunteers) with the purpose of verifying the effects of a product and/or identifying any adverse reactions, studying its absorption, distribution, metabolism, and excretion to establish its efficacy and tolerability. Clinical Trials must therefore confirm or refute the…